• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型人类免疫缺陷病毒包膜的体液免疫反应与早期感染疾病进展之间的相关性。

Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection.

作者信息

Loomis-Price L D, Cox J H, Mascola J R, VanCott T C, Michael N L, Fouts T R, Redfield R R, Robb M L, Wahren B, Sheppard H W, Birx D L

机构信息

H.M. Jackson Foundation, Walter Reed Army Institute of Research, Rockville, MD, USA.

出版信息

J Infect Dis. 1998 Nov;178(5):1306-16. doi: 10.1086/314436.

DOI:10.1086/314436
PMID:9780250
Abstract

Human immunodeficiency virus (HIV)-1-infected rapid and slow progressors showed differential humoral responses against HIV envelope peptides and proteins early in infection. Sera from slow progressors reacted more strongly with short envelope peptides modeling gp160NL4-3, predominantly in gp41. Reactivity to six peptides (in constant regions C3, C4, and C5 of gp120 and in gp41) correlated with slower progression. In a novel association, reactivity to three peptides (in constant regions C1 and C3 and variable region V3 of gp120) correlated with faster progression. Envelope peptide reactivity correlated with subsequent course of disease progression as strongly as did reactivity to gag p24. Patients heterozygous for 32-bp deletions in the CCR5 coreceptor reacted more frequently to an epitope in gp41. Rapid progressors had greater gp120 native-to-denatured binding ratios than did slow progressors. While antibody-dependent cellular cytotoxicity against gp120 did not strongly differentiate the groups, slow progressors showed a broader neutralization pattern against 5 primary virus isolates.

摘要

人类免疫缺陷病毒1型(HIV-1)感染的快速进展者和缓慢进展者在感染早期对HIV包膜肽和蛋白表现出不同的体液反应。缓慢进展者的血清与模拟gp160NL4-3的短包膜肽反应更强,主要在gp41区域。对六种肽(在gp120的恒定区C3、C4和C5以及gp41中)的反应性与疾病进展较慢相关。在一个新发现的关联中,对三种肽(在gp120的恒定区C1和C3以及可变区V3中)的反应性与疾病进展较快相关。包膜肽反应性与疾病进展的后续过程的相关性与对gag p24的反应性一样强。CCR5共受体中存在32bp缺失的杂合子患者对gp41中的一个表位反应更频繁。快速进展者的gp120天然与变性结合比率高于缓慢进展者。虽然针对gp120的抗体依赖性细胞毒性不能很好地区分这两组,但缓慢进展者对5种主要病毒分离株表现出更广泛的中和模式。

相似文献

1
Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection.1型人类免疫缺陷病毒包膜的体液免疫反应与早期感染疾病进展之间的相关性。
J Infect Dis. 1998 Nov;178(5):1306-16. doi: 10.1086/314436.
2
Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.在疾病进展迅速与缓慢的HIV-1血清转化者中,针对HIV-1包膜和核衣壳抗原决定簇的抗体反应
Virology. 1994 Jun;201(2):285-93. doi: 10.1006/viro.1994.1293.
3
B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.利用长(19至36个残基)合成肽对人类免疫缺陷病毒包膜糖蛋白进行B细胞表位图谱分析。
J Gen Virol. 1990 Jan;71 ( Pt 1):85-95. doi: 10.1099/0022-1317-71-1-85.
4
Correlation of Antibody Responses to a Peptide Antigen gp120-C5/gp41 with HIV Disease Progression.针对肽抗原gp120 - C5/gp41的抗体反应与HIV疾病进展的相关性
AIDS Res Hum Retroviruses. 2017 Jun;33(6):558-566. doi: 10.1089/AID.2016.0184. Epub 2017 Jan 31.
5
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.在CCR5限制性而非CXCR4利用型的原发性人类免疫缺陷病毒1型毒株的天然包膜糖蛋白寡聚体中,一个保守的、CD4诱导性V3环中和表位的隐秘性质。
J Virol. 2005 Jun;79(11):6957-68. doi: 10.1128/JVI.79.11.6957-6968.2005.
6
Search for epitope-specific antibody responses to the human immunodeficiency virus (HIV-1) envelope glycoproteins signifying resistance to disease development.寻找针对人类免疫缺陷病毒(HIV-1)包膜糖蛋白的表位特异性抗体反应,这些反应表明对疾病发展具有抗性。
AIDS Res Hum Retroviruses. 1990 Oct;6(10):1183-92. doi: 10.1089/aid.1990.6.1183.
7
Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.M组完整、天然、原代人类免疫缺陷病毒1型病毒体上保守且暴露的表位。
J Virol. 2000 Aug;74(15):7096-107. doi: 10.1128/jvi.74.15.7096-7107.2000.
8
Human immunodeficiency virus type 1 disease progression, CCR5 genotype, and specific immune responses.人类免疫缺陷病毒1型疾病进展、CCR5基因型与特异性免疫反应。
Clin Diagn Lab Immunol. 1998 Jul;5(4):463-6. doi: 10.1128/CDLI.5.4.463-466.1998.
9
N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.V3环和gp120免疫沉默面的N-连接糖基化可保护1型人类免疫缺陷病毒SF162免受抗gp120和抗gp41抗体的中和作用。
J Virol. 2004 Apr;78(7):3279-95. doi: 10.1128/jvi.78.7.3279-3295.2004.
10
Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels.人类免疫缺陷病毒1型(HIV-1)感染非进展和缓慢进展的预测因素:血清中低病毒RNA拷贝数以及维持高HIV-1 p24特异性而非V3特异性抗体水平。
J Infect Dis. 1995 Apr;171(4):811-21. doi: 10.1093/infdis/171.4.811.

引用本文的文献

1
Passively Acquired Constant Region 5-Specific Antibodies Associated With Improved Survival in Infants Who Acquire Human Immunodeficiency Virus.被动获得的恒定区5特异性抗体与感染人类免疫缺陷病毒的婴儿存活率提高相关。
Open Forum Infect Dis. 2023 Jun 14;10(7):ofad316. doi: 10.1093/ofid/ofad316. eCollection 2023 Jul.
2
The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study.治疗性HIV包膜蛋白C5/gp41候选疫苗Vacc-C5在一项I/II期临床研究中诱导了特异性T细胞调节。
BMC Infect Dis. 2017 Mar 24;17(1):228. doi: 10.1186/s12879-017-2316-x.
3
Pandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin.
大流行的HIV-1 Vpu克服了由束缚素介导的固有群体免疫。
Sci Rep. 2015 Jul 17;5:12256. doi: 10.1038/srep12256.
4
Comparison of the specificities of IgG, IgG-subclass, IgA and IgM reactivities in African and European HIV-infected individuals with an HIV-1 clade C proteome-based array.基于HIV-1 C亚型蛋白质组芯片对非洲和欧洲HIV感染个体中IgG、IgG亚类、IgA和IgM反应特异性的比较。
PLoS One. 2015 Feb 6;10(2):e0117204. doi: 10.1371/journal.pone.0117204. eCollection 2015.
5
Use of principal components analysis and protein microarray to explore the association of HIV-1-specific IgG responses with disease progression.运用主成分分析和蛋白质微阵列技术探究HIV-1特异性IgG反应与疾病进展之间的关联。
AIDS Res Hum Retroviruses. 2014 Jan;30(1):37-44. doi: 10.1089/AID.2013.0088. Epub 2013 Dec 9.
6
Variations in the Biological Functions of HIV-1 Clade C Envelope in a SHIV-Infected Rhesus Macaque during Disease Progression.疾病进展过程中,一只感染SHIV的恒河猴体内HIV-1 C亚型包膜蛋白生物学功能的变化
PLoS One. 2013 Jun 26;8(6):e66973. doi: 10.1371/journal.pone.0066973. Print 2013.
7
Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170).在一项前瞻性试验(A5170)中,HIV 中和抗体与治疗中断后较低的病毒载量相关。
AIDS. 2012 Jul 17;26(11):1452. doi: 10.1097/QAD.0b013e3283550b8e.
8
The Antibody Response against HIV-1.HIV-1 的抗体反应。
Cold Spring Harb Perspect Med. 2012 Jan;2(1):a007039. doi: 10.1101/cshperspect.a007039.
9
Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression.对1型人类免疫缺陷病毒的中和抗体反应广度受感染早期因素影响,但不影响疾病进展。
J Virol. 2009 Oct;83(19):10269-74. doi: 10.1128/JVI.01149-09. Epub 2009 Jul 29.
10
Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections.1型人类免疫缺陷病毒(HIV-1)和2型人类免疫缺陷病毒(HIV-2)感染的塞内加尔患者的异源中和抗体反应比较:广度和强度的不同模式区分HIV-1和HIV-2感染。
J Virol. 2007 May;81(10):5331-8. doi: 10.1128/JVI.02789-06. Epub 2007 Feb 14.